BlueRock Therapeutics Compagnie réclamée
BlueRock Therapeutics LP is a clinical stage cell therapy harnessing the power of cell therapy to create a pipeline of new medicines for people suffering from neurological and ophthalmic diseases. Two of our novel investigational cell therapies, bemdaneprocel (BRT-DA01) for the treatment of Parkinson’s disease and OpCT-001 for the treatment of primary photoreceptor diseases are clinical stage programs. BlueRock was founded in 2016 as a joint venture of Versant Ventures and Leaps by Bayer. Our culture is defined by the courage to persist regardless of the challenge, the urgency to transform medicine and deliver hope, integrity guided by mission, and community-mindedness with the understanding that we are all part of something bigger than ourselves.
Lire la suite
Fantastic culture and impactful science
Quelle est la meilleure partie de votre programme de rémunération?
Incentive bonuses tied to company milestones
Qu’est-ce qui vous rend le plus heureux au travail?
Ability to make an impact scientifically
Quelles sont les meilleures choses à propos de votre équipe?
Easy to communicate across sites
Qu’est-ce qui est le plus positif à propos de la culture et de l’environnement de votre entreprise?
Frequent team-building and community events
Qu’est-ce qui vous plaît le plus dans l’équipe de direction?
Leadership makes an effort to connect to employees across all levels and makes it clear that they are receptive to critical feedback. Feedback can be given anonymously via surveys and aggregate results are announced internally for accountability.
Other Employee Reviews for BlueRock Therapeutics
×